Lipid Metabolic Flux Analysis (Lipid-MFA)

Summary¶

Lipid Metabolic Flux Analysis (Lipid-MFA) is an analytical and computational framework designed to resolve and quantify fluxes across the lipidome. Developed by the Metallo Lab, it leverages stable isotope tracing (e.g., using $^{13}\text{C}$-glucose or $^{13}\text{C}$-serine), high-resolution mass spectrometry (LC-MS/MS), and network-based isotopologue modeling to measure metabolic pathways including de novo lipid synthesis, acyl-chain elongation, and endolysosomal lipid recycling.

Methodology and Assumptions¶

Lipid-MFA extends traditional metabolic flux analysis (which focuses on central carbon metabolism) to compound lipids. The core pipeline consists of: 1. Stable Isotope Tracing: Culturing cells or tissue slices with labeled precursors (such as $[U-^{13}\text{C}_6]\text{glucose}$ or $[U-^{13}\text{C}_3]\text{serine}$) to generate distinct mass isotopomer distributions (MIDs) in downstream lipids. 2. Mass Spectrometry: Quantifying MIDs in intact lipids (e.g., phosphatidylcholines, sphingomyelins) using ultra-high pressure liquid chromatography coupled to high-resolution mass spectrometry. 3. Stoichiometric Modeling: Simulating isotope propagation through lipid networks and fitting observed MIDs using flux analysis software like INCA.

Key Assumptions¶

The mathematical modeling of Lipid-MFA rests on three primary assumptions: - Metabolic Steady State: The biological system (cells or tissues) remains in a metabolic steady state during the tracking period. - Isotopic Precursor Steady State: Precursor pools (such as acetyl-CoA, serine, and glycerol-3-phosphate) reach isotopic steady state rapidly relative to downstream membrane lipids and triglycerides. - Exponential Growth: Cells proliferate exponentially, allowing the calculation of time-dependent fractional synthesis ($g(t)$) for each lipid species.

Biological Applications¶

Lipid-MFA has been successfully applied to: - Non-Small Cell Lung Cancer (NSCLC) Models: Characterizing differences in lipid synthesis and recycling in p53-deficient versus LKB1-deficient tumors. - Precision-Cut Lung Slices (PCLS): Quantifying trafficking and fluxes of lipids within complex microenvironments. - Drug Specificity Evaluation: Resolving the target selectivity of lipid-metabolizing inhibitors (such as Fumonisin B1) on ceramide synthase (CERS) isozymes.

Relationship to Genetically Predicted Flux¶

Lipid-MFA estimates realized pathway activity from isotope-label propagation in an experimental system. Metabolic flux modulation of genetic risk instead uses imputed organ gene expression and genome-scale stoichiometry to predict inherited differences in reaction activity across population cohorts.[2]

The approaches are complementary: genetic flux modeling scales to hundreds of thousands of people and minimizes environmental confounding, whereas isotope tracing measures biochemical turnover more directly but in smaller and experimentally constrained systems.

Citations¶

[2] Foguet et al. (2025), genetically predicted reaction flux and CAD risk - Wessendorf-Rodriguez, K., Ruchhoeft, M. L., Murray, C. W., Huang, Y., Ashley, E. L., Galvez, H. M., McGregor, G. H., Kambhampati, S., Shaw, R. J., & Metallo, C. M. (2026). Modeling lipid homeostasis using stable isotope tracing and flux analysis. Cell Metabolism, 38(3), 460–473. Source paper: 1-s2.0-S1550413126000203-main.pdf